Ionis Pharmaceuticals
Roche and Ionis expand partnership with new RNA programs for Alzheimerās and Huntingtonās
Anika Sharma
Roche, in its quest to find effective treatments for Alzheimer’s diseases after the setbacks of gantenerumab, has reaffirmed its commitment ...
Ionisā olezarsen slashes triglycerides and pancreatitis in rare disease patients
Anika Sharma
Ionis Pharmaceuticals has achieved a significant milestone in its phase 3 clinical trial for lipid-lowering therapy, bringing the company closer ...
Novartis Invests $60 Million Upfront in Ionis’ Innovative Cardiovascular Medication
SG Tylor
Source – Ionis Pharmaceuticals Novartis has enlisted Ionis to develop another drug for cardiovascular disease, investing $60 million in a ...
